Thursday, 11. March 2010



The RUBICON Network of Excellence




Our Research




News




Learn About...




Press Releases




Courses and Conferences




Video-Lectures




Meetings




RUBICON Protocols Database




Links




Job Opportunities



Welcome to RUBICON

RUBICON is a “Network of Excellence” funded by the Framework Programme 6 of the European Commission over a five years period (January 2006 – December 2010). It is coordinated by Professor Maria Masucci, Karolinska Institutet, Stockholm, Sweden.

News: C1a: 2010, March 14-18. RUBICON Joint Research...


Organizers: Aaron Ciechanover, Yinon Ben-Neriah, Ze’ev Ronai Sessions include: Structure, Biology and Pathology of UPS Components, SUMO, ER Stre...
» more
News: JO 080604: Postdoctoral positions and Informati...


Postdoctoral positions to work on SUMO and Ubiquitin in the laboratory of Professor Ron Hay, University of Dundee. Enthusiastic and highly motiv...
» more
News: LA6 - Versatile role of the yeast ubiquitin lig...


In this review, Rosine Haguenauer-Tsapis and collaborators discuss recent examples illustrating the role of Rsp5p in membrane protein trafficking a...
» more
News: C1c: 2010, October 4-7. ZOMES VI Conference, Sa...


The ZOMES meetings focus on the biology of the three “PCI” complexes, the proteasome, the COP9 signalosome, and eIF3, and also additional complexes...
» more
Participant: Alain Israël's Group
The group focuses on the analysis of two signaling pathways : NF-kappaB and Notch. More specifically, ex vivo approaches based on biochemical and g...
» more
Participant: Thomas Sommer's Group


The secretory pathway of eukaryotic cells harbors an elaborate protein quality control system, which prevents the accumulation of misfolded or unas...
» more
Participant: Matthias Mann's Group


The department of proteomics and signal transduction, led by Prof. Matthias Mann, was established in July 2005 and is currently comprised of 30 peo...
» more
Participant: DDF Research Group
DDF is involved in several drug discovery programs including finding new cures for prostate cancer, dendritic based cancer vaccines, osteoporosis a...
» more
Participant: Pepscan


The pharmaceutical company Pepscan Systems B.V. is operational since 1999. Pepscan has 25 employees including 11 technicians, and 10 PhD’s. The c...
» more
Participant: Pier Paolo Di Fiore's Group
Our lab has contributed to the characterization of two protein:protein interaction networks, the EH and the mono-ubiquitin (Ub) networks, which pla...
» more



SEARCH



»Advanced Search



OVERVIEWS

»Sitemap

»Institutions

»Members



LAST PAGES (3/5) show all
»
Navigation Field: Courses and Conferences
»
Participant: Anne Dejean's Group
»
Navigation Field: Job Opportunities


INFOBOX (0/0) show all
Your infobox is empty




Powered by AVERIS